课题基金 / 基金详情

Genomic prediction of response and resistance to PARP inhibition in breast cancer

Genomic prediction of response and resistance to PARP inhibition in breast cancer
乳腺癌对 PARP 抑制反应和耐药性的基因组预测
批准号：
301439
负责人：
Hassan Saima N
金额：
$8.74万
依托单位：
Oregon Health & Science University (Portland)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-11-01 至 2015-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=301439&lang=en
关键词：
Breast Cancer Dna Damage Pathways Integrated Genomic Characterization Microenvironment Model Parp Inhibition Predictive Biomarkers Therapeutic Response Therpeutic Resistance

项目摘要

项目成果

Hassan Saima N的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Although new treatments have helped improve the survival of breast cancer patients, the development of new therapies is challenging. Only a small number of therapeutic agents tested in the laboratory have demonstrated efficacy in patients. Laboratory mod
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomic prediction of response to PARP inhibition in breast cancer
海外基金